![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mayo Clara Bertran-Alamillo Jordi Molina-Vila Miguel Ángel Giménez-Capitán Ana Costa Carlota Rosell Rafael
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.13, Iss.7, 2012-05, pp. : 789-802
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets, Vol. 15, Iss. 14, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gefitinib, vinorelbine and EGFR mutations in lung cancer
Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. :